Daniel Menold

Companies

• CymaBay Therapeutics (United States)Vice President, Finance May 5, 2017 to Jan 16, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCymaBay Therapeutics (United States)0 shares²Jan 16, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 16, 2024Sold 10,000 shares at $23.58 of CymaBay Therapeutics (United States)²
• Jan 16, 2024Exercised options 10,000 shares at $4.05 of CymaBay Therapeutics (United States)²
• Dec 15, 2023Sold 11,497 shares at $21.99 of CymaBay Therapeutics (United States)³
• Dec 15, 2023Exercised options 11,497 shares at $8.43 of CymaBay Therapeutics (United States)³
• Dec 15, 2023Sold 10,000 shares at $21.98 of CymaBay Therapeutics (United States)³
• Dec 15, 2023Exercised options 10,000 shares at $4.05 of CymaBay Therapeutics (United States)³
• Nov 15, 2023Sold at $17.38 of CymaBay Therapeutics (United States)⁴
• Nov 15, 2023Exercised options 17,500 shares at $3.45 of CymaBay Therapeutics (United States)⁴
• Oct 16, 2023Sold at $13.76 of CymaBay Therapeutics (United States)⁵
• Oct 16, 2023Exercised options 17,500 shares at $3.45 of CymaBay Therapeutics (United States)⁵
• Sep 15, 2023Sold at $16.87 of CymaBay Therapeutics (United States)⁶
• Sep 15, 2023Exercised options 15,000 shares at $1.72 of CymaBay Therapeutics (United States)⁶
• Sep 15, 2023Sold at $16.87 of CymaBay Therapeutics (United States)⁶
• Sep 15, 2023Exercised options 1,545 shares at $1.82 of CymaBay Therapeutics (United States)⁶
• Aug 15, 2023Sold at $12.13 of CymaBay Therapeutics (United States)⁷
• Aug 15, 2023Exercised options 7,000 shares at $10.00 of CymaBay Therapeutics (United States)⁷
• Aug 15, 2023Sold at $11.92 of CymaBay Therapeutics (United States)⁷
• Aug 15, 2023Exercised options 8,500 shares at $1.06 of CymaBay Therapeutics (United States)⁷
• Aug 9, 2023Sold 20,945 shares at $12.35 of CymaBay Therapeutics (United States)⁸
• Aug 9, 2023Exercised options 20,945 shares at $5.00 of CymaBay Therapeutics (United States)⁸